Letter

Drug donations to Bosnia-Hercegovina are often inappropriate

BMJ 1996; 313 doi: 10.1136/bmj.313.7063.1011b (Published 19 October 1996)
Cite this as: BMJ 1996;313:1011.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Maurizio Bonati, Head,
  2. Gilles B Forte, Adviser,
  3. Kees DE Joncheere, Regional adviser for pharmaceuticals,
  4. Einar Magnusson, Director
  1. Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milan, Italy
  2. Programme for Pharmaceuticals, World Health Organisation, Regional Office for Europe, DK-2100 Copenhagen, Denmark
  3. Pharmaceutical Affairs, Ministry of Health and Social Security, IS-150 Reykjavik, Iceland

    EDITOR,—The programme for pharmaceuticals of the World Health Organisation's Regional Office for Europe recently carried out a situation analysis of the pharmaceuticals in Bosnia-Hercegovina. One striking finding was the large amount of unused drugs that originated from donations. This finding is not exclusive to Bosnia-Hercegovina, and urgent action is needed to prevent such situations in countries in transition.

    In Bosnia-Hercegovina 70–80% of drugs were reported to have been provided by humanitarian organisations, charities, and groups of …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular